Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients

Hypertension

Volumn 58, Issue 1, 2011, Pages 29-36

  De Ciuceis, Carolina ^a   Porteri, Enzo ^a   Rizzoni, Damiano ^a   Corbellini, Claudia ^a   La Boria, Elisa ^a   Boari, Gianluca E M ^a   Pilu, Annamaria ^a   Mittempergher, Francesco ^b   Di Betta, Ernesto ^b   Casella, Claudio ^b   Nascimbeni, Riccardo ^b   Rosei, Claudia Agabiti ^a   Ruggeri, Giuseppina ^a   Caimi, Luigi ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Department of Medical and Surgical Sciences ^*  (Italy)

Author keywords

hypertension; microcirculation; obesity; remodeling; small arteries

Indexed keywords

ACETYLCHOLINE;

ABDOMINOPLASTY; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BARIATRIC SURGERY; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; HYPERTENSION; MALE; MICROCIRCULATION; MORPHOLOGY; MYOGRAPHY; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SUBCUTANEOUS FAT; SUBCUTANEOUS SMALL ARTERY; TUNICA MEDIA; VASCULITIS; VASODILATATION; WEIGHT REDUCTION;

ADULT; ARTERIOLES; BIOPSY; BLOOD PRESSURE; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOGRAPHY; OBESITY, MORBID; PROGNOSIS; RETROSPECTIVE STUDIES; SUBCUTANEOUS TISSUE; VASCULAR RESISTANCE; WEIGHT LOSS;

EID: 79959761532     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.171082     Document Type: Article

References (43)

1. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev. 1990;70:921-971.
2. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17: 1192-1200. (Pubitemid 40029420)
3. Agabiti Rosei E, Rizzoni D. The effects of hypertension on the structure of human resistance arteries. In: Comprehensive Hypertension, Lip GYH and Hall JE eds. Amsterdam, The Netherlands: Mosby Elsevier; 2007: 579-590.
4. Rizzoni D, De Ciuceis C, Porteri E, Paiardi S, Boari GE, Mortini P, Cornali C, Cenzato M, Rodella LF, Borsani E, Rizzardi N, Platto C, Rezzani R, Agabiti Rosei E. Altered structure of small cerebral arteries in patients with essential hypertension. J Hypertens. 2009;27:838-845.
5. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual process of remodeling and growth. Hypertension. 1993;21:391-397. (Pubitemid 23095149)
6. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Agabiti Rosei E. Structural alterations in subcutaneous small arteries of normotensive and hyper- tensive patients with non insulin dependent diabetes mellitus. Circulation. 2001;103:1238-1244. (Pubitemid 32221346)
7. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti Rosei E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension. 1996;28:785-790. (Pubitemid 26365519)
8. Heerkens EH, Izzard AS, Heagerty AM. Integrins, vascular remodeling, and hypertension. Hypertension. 2007;49:1-4. (Pubitemid 46360326)
9. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci. 2002;17:105-109.
10. Rizzoni D, Porteri E, Giustina A, De Ciuceis C, Sleiman I, Boari GE, Castellano M, Muiesan ML, Bonadonna S, Burattin A, Cerudelli B, Agabiti-Rosei E. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension. 2004;43:561-565. (Pubitemid 38282428)
11. Schofield I, Malik R, Izzard A, Austin C, Heagerty AM. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the role of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002;106: 3037-3043. (Pubitemid 35440285)
12. Rizzoni D, Porteri E, Boari GEM, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small artery structure in hypertension. Circulation. 2003;108:2230-2235. (Pubitemid 37363040)
13. De Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GEM, Miclini M, Zani F, Muiesan ML, Donato F, Salvetti M, Castellano M, Tiberio GA, Giulini SM, Agabiti Rosei E. Structural alterations of subcutaneous small arteries may predict major cardiovascular events in hypertensive patients. Am J Hypertens. 2007;20:846-852. (Pubitemid 47176353)
14. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens. 2005;23:247-250. (Pubitemid 40279623)
15. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozàkovà M, La Canna G, Nardi M, Guelfi D, Salvetti M, Morizzo C, Vittone F, Agabiti Rosei E. Relationships between coronary vasodilator capacity and small artery remodeling in hypertensive patients. J Hypertens. 2003;21:625-632.
16. Schlaich MP, Grassi G, Lambert GW, Straznicky N, Esler MD, Dixon J, Lambert EA, Redon J, Narkiewicz K, Jordan J; European Society of Hypertension Working Group on Obesity; Australian and New Zealand Obesity Society. European Society of Hypertension Working Group on Obesity-Induced Hypertension and Target Organ Damage: current knowledge and future directions. J Hypertens. 2009, 27:207-211.
17. Frisbee JC. Obesity, insulin resistance, and microvessel density. Microcirculation. 2007;14:289-298. (Pubitemid 47050022)
18. Iyer A, Fairlie DP, Prins JB, Hammock BD, Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol. 2010; 6:71-82.
19. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J. 2009;276:5747-5754.
20. Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis. 2010;20:72-77.
21. Grassi G, Seravalle G, Scopelliti F, Dell'Oro R, Fattori L, Quarti-Trevano F, Brambilla G, Schiffrin EL, Mancia G. Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity. Obesity. 2010;18:92-98.
22. Grassi G, Seravalle G, Brambilla G, Facchetti R, Bolla G, Mozzi E, Mancia G. Impact of the metabolic syndrome on subcutaneous microcirculation in obese patients. J Hypertens. 2010;28:1708-1714.
23. Crepaldi G, Belfiore F, Bosello O, Caviezel F, Contaldo F, Enzi G, Melchionda N. Italian Consensus Conference: overweight, obesity and health. Int J Obes. 1991;15:781-790.
24. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
25. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61:181-186. (Pubitemid 17137117)
26. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978;43:854-864.
27. De Ciuceis C, Pilu A, Cappelli C, Porteri E, Zani F, Santoro A, Gandossi E, Boari GE, Rizzardi N, Castellano M, Rizzoni D, Agabiti Rosei E. Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism. J Endocrinol Invest. [Epub ahead of print June 28, 2010].
28. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
29. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM; for the Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752. (Pubitemid 47295641)
30. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-323. (Pubitemid 351159368)
31. Grassi G, Diez J. Obesity-related cardiac and vascular structural alterations: beyond blood pressure overload. J Hypertens. 2009;27: 1750-1752.
32. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Tiberio G, Giulini SM, Rossi G, Bernini G, Agabiti-Rosei E. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension. 1998;31:335-341.
33. Rizzoni D, Agabiti-Rosei E. Endothelial factors and microvascular hypertensive disease. J Cardiovasc Pharmacol. 2001;38(suppl 2):S15-S18.
34. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti A. Endothelium, aging, and hypertension. Curr Hypertens Rep. 2006;8:84-89.
35. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension. 2001;38:581-587.
36. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci. 2007;112:375-384. (Pubitemid 46587452)
37. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-368. (Pubitemid 40165345)
38. Rizzoni D, Porteri E, De Ciuceis C, Boari GE, Zani F, Miclini M, Paiardi S, Tiberio GA, Giulini SM, Muiesan ML, Castellano M, Agabiti Rosei E. Lack of prognostic role of endothelial dysfunction in subcutaneous small resistance arteries of hypertensive patients. J Hypertens. 2006;24: 867-873. (Pubitemid 43670457)
39. Rizzoni D, Agabiti Rosei E. Small artery remodeling in diabetes mellitus. Nutr Metab Cardiovasc Dis. 2009;19:587-592.
40. Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker- Boudier HA. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008;118: 968-976.
41. Paiardi S, Rodella LF, De Ciuceis C, Porteri E, Boari GE, Rezzani R, Rizzardi N, Platto C, Tiberio GA, Giulini SM, Rizzoni D, Agabiti-Rosei E. Immunohistochemical evaluation of microvascular rarefaction in hypertensive humans and in spontaneously hypertensive rats. Clin Hemorheol Microcirc. 2009;42:259-268.
42. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes. 2006;30:400-418.
43. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009; 119:1661-1670.